Obesity and the Obesity Paradox in Heart Failure

Canadian Journal of Cardiology

Volumn 31, Issue 2, 2015, Pages 195-202

  Gupta, Pritha P ^a,b   Fonarow, Gregg C ^a,b   Horwich, Tamara B ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

BODY COMPOSITION; BODY MASS; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR RISK; HEART FAILURE; HUMAN; OBESITY; PRACTICE GUIDELINE; PREVALENCE; PROGNOSIS; REVIEW; SKINFOLD THICKNESS; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WEIGHT REDUCTION; COMPLICATION; DISEASE COURSE; HEALTH; INCIDENCE; RISK FACTOR; SURVIVAL RATE; TRENDS;

BODY MASS INDEX; DISEASE PROGRESSION; GLOBAL HEALTH; HEART FAILURE; HUMANS; INCIDENCE; OBESITY; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; WEIGHT LOSS;

EID: 84924989431     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.08.004     Document Type: Review

References (56)

1. Counihan T.B. Heart failure due to extreme obesity. Br Heart J 1956, 18:425-426.
2. Seide M.J. Heart failure due to extreme obesity; report of a case, with autopsy findings. NEngl J Med 1957, 257:1227-1230.
3. Kasper E.K., Hruban R.H., Baughman K.L. Cardiomyopathy of obesity: a clinicopathologic evaluation of 43 obese patients with heart failure. Am J Cardiol 1992, 10:921-924.
4. Bozkurt B., Deswal A. Obesity as a prognostic factor in chronic symptomatic heart failure. Am Heart J 2005, 150:1233-1239.
5. Butler J., Howser R., Portner P.M., Pierson R.N. Body mass index and outcomes after left ventricular assist device placement. Ann Thorac Surg 2005, 79:66-73.
6. Cicoira M., Maggioni A., Latini R., et al. Body mass index, prognosis and mode of death in chronic heart failure: results from the Valsartan Heart Failure Trial. Eur J Heart Fail 2007, 9:397-402.
7. Davos C., Dowhner W., Rauchhaus M., et al. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. JCard Fail 2003, 9:29-35.
8. Gustafsson F., Kragelund C.B., Torp-Pedersen C., et al. Effect of obesity and being overweight on long-term mortality in congestive heart failure: influence of left ventricular systolic function. Eur Heart J 2005, 26:58-64.
9. Kenchaiah S., Pocock S.J., Wang D., et al. Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation 2007, 116:627-636.
10. Hall J., French T.K., Rasmusson K.D., et al. The paradox of obesity in patients with heart failure. JAm Acad Nurse Pract 2005, 17:542-546.
11. Kristorp C., Faber J., Galatius S., et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 2005, 112:1756-1762.
12. Lavie C.J., Cahalin L.P., Chase P., et al. Impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure. Mayo Clin Proc 2013, 88:251-258.
13. Padwal R., McAlister F.A., McMurray, et al. The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data. Int J Obes (Lond) 2014, 38:1110-1114.
14. Kenchaiah S., Evans J.C., Levy D., et al. Obesity and the risk of heart failure. NEngl J Med 2002, 347:305-313.
15. Kenchaiah S., Sesso H.D., Gaziano J.M. Body mass index and vigorous physical activity and the risk of heart failure among men. Circulation 2009, 119:44-52.
16. Levitan E.B., Yang A.Z., Wolk A., Mittleman M.A. Adiposity and incidence of heart failure hospitalization and mortality: a population-based prospective study. Circ Heart Fail 2009, 2:202-208.
17. Schmidt M., Bøtker H.E., Pedersen L., Sørensen H.T. Young adulthood obesity and risk of acute coronary syndromes, stable angina pectoris, and congestive heart failure: a 36-year cohort study. Ann Epidemiol 2014, 25:356-361.
18. Alpert M.A., Omran J., Mehra A., Ardhanari S. Impact of obesity and weight loss on cardiac performance and morphology in adults. Prog Cardiovasc Disc 2014, 56:391-400.
19. Lauer M.S., Anderson K.M., Kannel W.B., Levy D. The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. JAMA 1991, 266:231-236.
20. Granér M., Siren R., Nyman K., et al. Cardiac steatosis associates with visceral obesity in nondiabetic obese men. JClin Endocrinol Metab 2013, 98:1189-1197.
21. Bradley T.D., Floras J.S. Sleep apnea and heart failure: part I: obstructive sleep apnea. Circulation 2003, 107:1671-1678.
22. Abel E.D., Litwin S.E., Sweeney G. Cardiac remodeling in obesity. Physiol Rev 2008, 88:389-419.
23. Avelar E., Cloward T.V., Walker J.M., et al. Left ventricular hypertrophy in severe obesity: interactions among blood pressure, nocturnal hypoxemia, and body mass. Hypertension 2007, 49:34-39.
24. Crisostomo L.L., Araújo L.M., Cámara E., et al. Comparison of left ventricular mass and function in obese versus nonobese women <40 years of age. Am J Cardiol 1999, 84:1127-1129. A11.
25. Iacobellis G. True uncomplicated obesity is not related to increased left ventricular mass and systolic dysfunction. JAm Coll Cardiol 2004, 44:2257. author reply 2258.
26. Iacobellis G., Ribaudo M.C., Leto G., et al. Influence of excess fat on cardiac morphology and function: study in uncomplicated obesity. Obes Res 2002, 10:767-773.
27. Aurigemma G.P., Silver K.H., Priest M.A., Gaasch W.H. Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy. JAm Coll Cardiol 1995, 26:195-202.
28. Wilhelmsen L., Rosengren A., Eriksson H., Lappas G. Heart failure in the general popularion of men-morbidity, risk factors and prognosis. JIntern Med 2001, 149:253-261.
29. Horwich T.B., Broderick S., Chen L., et al. Relation among body mass index, exercise training, and outcomes in chronic systolic heart failure. Am J Cardiol 2011, 108:1754-1759.
30. Kapoor J.R., Heidenreich P.A. Obesity and survival in patients with heart failure and preserved systolic function: a U-shaped relationship. Am Heart J 2010, 159:75-80.
31. Adams K.F., Mathur V.S., Gheorghiade M. B-type natriuretic peptide: from bench to bedside. Am Heart J 2003, 145:S34-46.
32. Sarzani R., Dessí-Fulgheri P., Paci V.M., Espinosa E., Rappelli A. Expression of natriuretic peptide receptors in human adipose and other tissues. JEndocrinol Invest 1996, 19:581-585.
33. Sengenés C., Berlan M., De Glisezinski I., Lafontan M., Galitzky J. Natriuretic peptides: a new lipolytic pathway in human adipocytes. FASEB J 2000, 14:1345-1351.
34. Mehra M.R., Uber P.A., Park M.H., et al. Obesity and suppressed B-type natriuretic peptide levels in heart failure. JAm Coll Cardiol 2004, 43:1590-1595.
35. Horwich T.B., Fonarow G.C., Hamilton M.A., MacLellan W.R., Woo M.A., Tillisch J.H. The Relationship between obesity and mortality in patients with heart failure. JAm Coll Cardiol 2001, 38:789-795.
36. Oreopoulos A., Padwal R., Kalantar-Zadeh K., et al. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 2008, 156:13-22.
37. Fonarow G.C., Srikanthan P., Costanzo M.R., Cintron G.B., Lopatin M., ADHERE Scientific Advisory Committee and Investigators An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J 2007, 153:74-81.
38. Shah R., Gayat E., Januzzi J.L., et al. Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradox. JAm Coll Cardiol 2014, 63:778-785.
39. Zamora E., Lupón J., de Antonio M., et al. The obesity paradox in heart failure: is etiology a key factor?. Int J Cardiol 2013, 166:601-605.
40. Clark A.L., Chyu J., Horwich T.B. The obesity paradox in men versus women with systolic heart failure. Am J Cardiol 2012, 110:77-82.
41. Anker S.D., Ponikowski P., Varney S., et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 1997, 349:1050-1053.
42. Nagarajan V., Cauthen C.A., Starling R.C., Tang W.H. Prognosis of morbid obesity patients with advanced heart failure. Congest Heart Fail 2013, 19:160-164.
43. Janssen I., Katzmarzyk P.T., Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr 2004, 79:379-384.
44. Bigaard J., Frederiksen K., Tjønneland A., et al. Waist circumference and body composition in relation to all-cause mortality in middle-aged men and women. Int J Obes (Lond) 2005, 29:778-784.
45. Clark A.L., Fonarow G.C., Horwich T.B. Waist circumference, body mass index, and survival in systolic heart failure: the obesity paradox revisited. JCard Fail 2011, 17:374-380.
46. Futter J.E., Cleland J.G., Clark A.L. Body mass indices and outcomes in patients with chronic heart failure. Eur J Heart Fail 2011, 13:207-213.
47. Buch E., Bradfield J., Larson T., Horwich T. Effect of bioimpedance body composition analysis on function of implanted cardiac devices. Pacing Clin Electrophysiol 2012, 35:681-684.
48. Thomas E., Clark A.L., Fonarow G.C., Horwich T.B. Use of bioelectrical impedance analysis to assess body composition in heart failure patients. JCard Fail 2012, 18:S69.
49. Bosy-Westphal A., Danielzik S., Dörhöfer R.P., Piccoli A., Müller M.J. Patterns of bioelectrical impedance vector distribution by body mass index and age: implications for body-composition analysis. Am J Clin Nutr 2005, 82:60-68.
50. Piccoli A., Italian CAPD-BIA Study Group Bioelectric impedance vector distribution in peritoneal dialysis patients with different hydration status. Kidney Int 2004, 65:1050-1063.
51. Chase P., Arena R., Myers J., et al. Relation of the prognostic value of ventilatory efficiency to body mass index in patients with heart failure. Am J Cardiol 2008, 101:348-352.
52. O'Connor C.M., Whellan D.J., Lee K.L., et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 2009, 301:1439-1450.
53. Yancy C.W., Jessup M., Bozkurt B., et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2013, 128:1810-1852.
54. Heart Failure Society of America, Lindenfeld J., Albert N.M., Boehmer J.P., et al. HFSA 2010 comprehensive heart failure practice guideline. JCard Fail 2010, 16:e1-194.
55. McMurray J.J., Adamopoulos S., Anker S.D., et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012, 33:1787-1847.
56. Ramani G.V., McCloskey C., Ramanathan R.C., Mathier M.A. Safety and efficacy of bariatric surgery in morbidly obese patients with severe systolic heart failure. Clin Cardiol 2008, 31:516-520.